MindWalk Holdings Corp. achieved its third consecutive quarter of year-over-year revenue growth, reporting a 52% increase, while solidifying its market position with a groundbreaking one-year enterprise Lens AI platform contract.

• Revenue for Q3 fiscal year 2026 reached $4.2 million, reflecting a 52% increase from the previous year, driven primarily by growth in the U.S. market.
• The company's largest enterprise client signed a one-year contract for the Lens AI platform, transitioning to a recurring revenue model that enhances predictability and reduces the need for continuous reselling.
• Significant advancements in pipeline programs for dengue and influenza are ongoing, with promising data readouts expected soon, showcasing the unique capabilities of MindWalk's HIFT technology.
• The dengue program aims to address a major global health concern by focusing on balanced immunity across multiple serotypes, advancing to neutralization tests following successful immunization studies.